UNC0642, a well-known EHMT1/2 selective inhibitor, has been widely reported to inhibit the growth of multiple kinds of cancer cells including neuroblastoma, melanoma, bladder cancer, non-small cell lung cancer, etc. [31, 35–37]. This evidence concerns the gene EHMT1 and urinary bladder carcinoma.